Correlation Between Royalty Pharma and AVROBIO

Can any of the company-specific risk be diversified away by investing in both Royalty Pharma and AVROBIO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royalty Pharma and AVROBIO into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Royalty Pharma Plc and AVROBIO, you can compare the effects of market volatilities on Royalty Pharma and AVROBIO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royalty Pharma with a short position of AVROBIO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royalty Pharma and AVROBIO.

Diversification Opportunities for Royalty Pharma and AVROBIO

-0.64

Correlation Coefficient

Royalty Pharma  AVROBIO

Excellent diversification

The 3 months correlation between Royalty and AVROBIO is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Royalty Pharma Plc and AVROBIO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AVROBIO and Royalty Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royalty Pharma Plc are associated (or correlated) with AVROBIO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AVROBIO has no effect on the direction of Royalty Pharma i.e., Royalty Pharma and AVROBIO go up and down completely randomly.

Pair Corralation between Royalty Pharma and AVROBIO

If you would invest  140.00  in AVROBIO on September 27, 2024 and sell it today you would earn a total of  0.00  from holding AVROBIO or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	1.59%
Values	Daily Returns

Royalty Pharma Plc  vs.  AVROBIO

Royalty Pharma Plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Royalty Pharma Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

AVROBIO

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AVROBIO has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, AVROBIO is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Royalty Pharma and AVROBIO

The main advantage of trading using opposite Royalty Pharma and AVROBIO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royalty Pharma position performs unexpectedly, AVROBIO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will offset losses from the drop in AVROBIO's long position.

The idea behind Royalty Pharma Plc and AVROBIO pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.